Drug discovery stories

AI and Genetics Research Identifies New Drug Targets and Candidates for Osteoarthritis Treatment

Researchers at the University of Utah Health have used artificial intelligence and genetic analysis to identify molecular signals and drug candidates that could modify osteoarthritis disease progression, moving beyond current symptom-management approaches. The research includes insights into purinergic signaling pathways that influence joint inflammation and cartilage degeneration.